Skip to content
QUBICON.AIAim Beyond Horizon

Industry practice

Compress discovery from years to weeks — inside the guardrails

AI now sits at the centre of the discovery pipeline: protein-structure and interaction models let teams reason about targets in hours, generative models propose candidate molecules and antibodies, ML-optimised CRISPR guides cut off-target edits, and self-driving labs run thousands of experiments a day. We train discovery-stage biotech, genomics and synthetic-bio teams to use these systems rigorously — with validation discipline and a regulatory-ready posture.

0%
literature/discovery time saved
0×
experiment throughput in labs
0+
biotech teams trained

What we deliver

Engineered for measured outcomes

AI-accelerated drug discovery, genomics and synthetic biology.

Clinicians in scrubs conferring over a tablet
In the field
  • Protein-structure and interaction models in target work
  • Generative molecule and antibody design with validation gates
  • ML-based CRISPR guide optimisation and off-target analysis
  • Self-driving-lab closed-loop experiment design
  • Evidence documentation for publication and regulators

Start here

Programs teams pair with biotech & genomics

Start today

Bring biotech & genomics excellence to your organisation

One working session with our principals turns this page into your programme plan.